AMLprofiler.

The AMLprofiler simplifies the challenging task to recognize Acute Myeloid Leukemia subtypes and make individualized therapy decisions. It delivers faster results and improved patient classification on an integrated and validated array platform.Lees meer

Companion Diagnostics.

Skyline is your partner of choice to develop signature-based tests to identify patient groups with favorable response profiles.Lees meer

 

Inlicensing.

As an innovative company, Skyline is actively seeking academic and industrial partners for development of novel diagnostic products. If you have developed a diagnostic signature, published or unpublished, please contact us.Lees meer

Skyline.

Skyline Diagnostics aims to become a leader in the field of molecular medicine by developing and commercializing innovative, signature-based diagnostics with a high clinical value that help to provide patients worldwide with the best individual care possible. Lees meer

 
Henk Bob Maarten Pieter Peter Rob
 
  • pharma

    Pharmaceutical companies

    Patient stratification and prevention of adverse side effects are rapidly becoming as important as traditional properties of therapeutics like efficacy, pharmacology and toxicity. Skyline is your partner of choice to develop signature-based tests to identify patient groups with favorable response profiles.

    Read more
     
  • scientists

    Scientists

    Skyline Diagnostics is a pioneering company with a tangible vision on translating discoveries from the laboratory directly to the daily practice of diagnostics. This process starts with synergistic collaborations with outstanding scientists. Step by step we prepare their discoveries for the market through further analysis and clinical validation.

    Read more
     
  • businesspartners

    Business partners

    Skyline is proud to have long-lasting collaborations with companies that are experts in their fields, including Affymetrix, Crosslinks, Iperion, Rescop and Myraqa.

    Read more
     
  • arts

    Medical professionals

    Treatment selection is always your responsibility in the end. You are the only person who can weigh all available information to make the best choice for your patient, together with your patient. The AMLprofiler is just a tool to help you making these important decisions.

    Read more
     
  • investors2

    Investors

    In November 2007 and in December 2009, Skyline Diagnostics completed two financing rounds. The current shareholders are Erasmus MC Biomedical Fund, LSP and Vesalius Biocapital. Click here for more information for investors.

    Read more
     
  • healthinsurance

    Health Insurance Companies

    The promise of personalized medicine is better healthcare at lower costs. We focus on developing diagnostic assays that help to select the right treatment for the right patient.

    Read more
     
 

Dr. Molewaterplein 50, Suite Ee1971, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com